DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Supported the introduction of the Reentry Act (H.R. 2400) in the House.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA | — |
| GRANT SMITH | — |
Law Enforcement/Crime/Criminal Justice LAW
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL LISZEWSKI | — |
| MARITZA PEREZ MEDINA | — |
| HANNA SHARIF-KAZEMI New | — |
Budget/Appropriations BUD
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA New | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.